Newsroom

Press Releases

May 21, 2024

CancerVax Successfully Uses Nobel Prize Chemistry to Achieve Universal Cancer Vaccine Targeting Milestone

CancerVax, Inc., the developer of breakthrough cancer drugs that will use the body’s immune system to fight cancer, today announced that its UCLA research team has achieved a critical milestone by creating a process to add any antibody to lipid nanoparticles (LNP) using “click chemistry”, for targeting cancer cells

April 16, 2024

CancerVax Announces Promising New Drug to Treat a Deadly Children’s Cancer

CancerVax, Inc., the developer of breakthrough cancer drugs that will use the body’s immune system to fight cancer, today announced that its UCLA research team has created a promising new drug candidate for treating recurrent Ewing sarcoma, a deadly children’s cancer

April 3, 2024

CancerVax Launches $5 Million Funding Round

CancerVax, Inc., developer of a breakthrough Universal Cancer Vaccine treatment that will use the body’s immune system to fight cancer, today announced that its Reg A+ offering has been qualified by the SEC allowing the Company to formally launch a funding round of up to $5 million. Proceeds from the SEC qualified Reg A+ offering will be used by the Company to continue work on its breakthrough cancer treatments

November 2, 2023

CancerVax CEO Ryan Davies Discusses Cancer Drug Development with Dr. Ezra Cohen

CancerVax, Inc., developer of a breakthrough universal cancer vaccine that uses the body’s immune system to fight cancer, today announced that in a recent Company podcast its CEO, Ryan Davies, and Tempus Labs Chief Medical Officer for Oncology Dr. Ezra Cohen, discussed his time at Tempus Labs, Moores Cancer Center and University of Chicago

News Commentary

Thumbnail

- June 3, 2024 - CancerVax News Commentary

Thumbnail

- May 27, 2024 - CancerVax News Commentary

Thumbnail

- May 20, 2024 - CancerVax News Commentary

CancerVax In The News

news November 12, 2023

22 Entrepreneurs Explain What Being a CEO Means to Them

news October 12, 2023

Ryan Davies Shares Insights on CancerVax and the Future of Cancer Treatment

news October 5, 2023

Challenges and Opportunities in the Treatment of Ewing Sarcoma

news OCTOBER 6, 2023

Santa Barbara firm partners with UCLA for new cancer treatments

news September 26, 2023

18 Entrepreneurs Share Some of The Best Leadership CEO Hacks and Resources

news September 23, 2023

Cancer Vaccines: Where are We Now and Where are We Going?

news August 14, 2023

Serial Entrepreneur Using Science to Tackle the Biggest Disease with Founder Ryan Davies | Ep 693

news July 24, 2023

Labiotech: Sarcoma Research: Is a Breakthrough in Sight?

news July 14, 2023

Healthcare Business Today: Scientists Have Found The Silver Bullet for Pediatric Cancer

news June 22, 2023

HealthLeaders: CancerVax CEO Sees a Homerun With Breakthrough Cancer Vaccine

news July 14, 2023

Scientists Have Found The Silver Bullet For Pediatric Cancer

news JUNE 22, 2023

CancerVax CEO Sees a Home Run With Breakthrough Universal Cancer Vaccine